Coronary Stents - Global Strategic Business Report

The global market for Coronary Stents was estimated at US$9.9 Billion in 2024 and is projected to reach US$13.6 Billion by 2030, growing at a CAGR of 5.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Coronary Stents market.

Global Coronary Stents Market - Key Trends & Drivers Summarized

Coronary stents are small, expandable tubes that are inserted into narrowed or blocked coronary arteries to restore blood flow to the heart. These devices play a crucial role in the treatment of coronary artery disease (CAD), which is a leading cause of morbidity and mortality worldwide. Stents help to keep the arteries open after procedures such as angioplasty, where a balloon is used to widen the artery. There are different types of coronary stents, including bare-metal stents (BMS), drug-eluting stents (DES), and bioresorbable stents. Drug-eluting stents are coated with medication that helps prevent the re-narrowing of the artery, while bioresorbable stents gradually dissolve after providing support to the artery.

The development and evolution of coronary stents have been driven by advancements in medical technology and materials science. Early bare-metal stents provided structural support but were associated with a higher risk of restenosis, or re-narrowing of the artery. The introduction of drug-eluting stents significantly reduced this risk by releasing antiproliferative drugs that inhibit the growth of scar tissue. More recently, bioresorbable stents have been developed to provide temporary support and then dissolve, potentially reducing long-term complications. Innovations in stent design, such as thinner struts and enhanced flexibility, have improved the deliverability and performance of stents, making them safer and more effective. Furthermore, advances in imaging and diagnostic technologies have enhanced the precision of stent placement, improving patient outcomes.

The growth in the coronary stent market is driven by several factors. Firstly, the increasing prevalence of coronary artery disease, driven by factors such as aging populations, unhealthy lifestyles, and rising rates of obesity and diabetes, is boosting the demand for stents. Secondly, advancements in stent technology, including the development of next-generation drug-eluting stents and bioresorbable stents, are driving market growth by offering improved safety and efficacy. Thirdly, the expansion of healthcare infrastructure and access to advanced medical treatments in emerging economies is increasing the adoption of coronary stents. Additionally, the growing awareness among patients and healthcare providers about the benefits of minimally invasive procedures for treating CAD is supporting market expansion. Lastly, supportive government policies, healthcare funding, and reimbursement frameworks are facilitating the adoption of advanced stent technologies, ensuring better patient care and driving market growth.

SCOPE OF STUDY:

The report analyzes the Coronary Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

• Segments: Type (Drug Eluting Stents, Other Types); End-User (Hospitals, Ambulatory Surgery Centers, Other End-Users)
• Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Drug Eluting Stents segment, which is expected to reach US$9.6 Billion by 2030 with a CAGR of a 5.6%. The Other Types segment is also set to grow at 5.1% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $2.8 Billion in 2024, and China, forecasted to grow at an impressive 7.2% CAGR to reach $1.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Coronary Stents Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Coronary Stents Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Coronary Stents Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abbott Cardiovascular, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International Group Ltd., BIOTRONIK SE & Co. KG and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 60 companies featured in this Coronary Stents market report include:

• Abbott Cardiovascular
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Biosensors International Group Ltd.
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• Cook Medical Inc.
• Elixir Medical Corporation
• Lepu Medical Technology (Beijing) Co., Ltd.
• Medtronic PLC
• Meril Life Sciences Pvt. Ltd.
• Microport Scientific Corporation
• Sahajanand Medical Technologies Ltd.
• Terumo Europe N.V.
• Translumina GmbH

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.